Study of huperzine A oral solution in healthy volunteers
This study tests how a liquid form of huperzine A moves through the body. It is for healthy people to help us learn more about the drug's effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- Your body mass index (BMI) is between 19 and 26.
- Men must weigh at least 50 kg (110 lbs), women at least 45 kg (99 lbs).
- You have no major allergies, especially to huperzine A or sodium benzoate.
- You have no history of stomach bleeding or conditions that increase bleeding risk.
- You are not taking any medications, supplements, or vaccines before the study.
- You agree to avoid smoking, alcohol, caffeine, and certain foods during the study.
- Females cannot be pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial is testing a new drug called HX15001 in healthy adults to see how safe it is and how the body processes it. It may help researchers decide if the drug can be tested in people with a specific condition in the future.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
Hear when a new Healhty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.